Intervention Act of 2001’’ or the ‘‘Children’s Lead SAFE
Act’’.
(b) TABLE OF CONTENTS.—The table of contents of
this Act is as follows:
Sec. 1. Short title; table of contents.
Sec. 2. Findings and purposes.
Sec. 3. Increased lead poisoning screenings and treatments under the medicaid
program.
Sec. 4. Bonus program for improvement of childhood lead screening rates.
Sec. 5. Authorization to use SCHIP funds for blood lead screening.
Sec. 6. Lead poisoning screening for the Head Start and Early Head Start pro-
grams.
Sec. 7. Lead poisoning screening for special supplemental nutrition program for
Women, Infants, and Children (WIC).
Sec. 8. Effective date.
SEC. 2. FINDINGS AND PURPOSES.
(a) FINDINGS.—Congress finds that—
(1) lead poisoning remains a serious environ-
mental risk, especially to the health of young chil-
dren;
(2) childhood lead poisoning can cause reduc-
tions in IQ, attention span, reading, and learning
disabilities, and other growth and behavior problems;
(3) children under the age of 6 are at the great-
est risk of suffering the effects of lead poisoning be-
cause of the sensitivity of their developing brains
and nervous systems, while children under the age of
3 are especially at risk due to their stage of develop-
ment and hand-to-mouth activities;
(4) poor children and minority children are at
substantially higher risk of lead poisoning;
(5) three-fourths of all children ages 1 through
5 found to have an elevated blood lead level in a
Centers for Disease Control and Prevention nation-
ally representative sample were enrolled in or tar-
geted by Federal health care programs, specifically
the medicaid program, the special supplemental nu-
trition program for women, infants, and children
(WIC), and the community health centers programs
under section 330 of the Public Health Service Act,
equating to an estimated 688,000 children nation-
wide;
(6) the General Accounting Office estimates
that 2⁄3 of the 688,000 children who have elevated
blood lead levels and are enrolled in or targeted by
Federal health care programs have never been
screened for lead;
(7) although the Health Care Financing Admin-
istration 
has 
required 
mandatory 
blood 
lead
screenings for children enrolled in the medicaid pro-
gram who are not less than 1 nor more than 5 years
of age, less than 20 percent of these children have
received such screenings;
(8) the Health Care Financing Administration
mandatory screening policy has not been effective, or
sufficient, to properly identify and screen children
enrolled in the medicaid program who are at risk;
(9) only about 1⁄2 of State programs have
screening policies consistent with Federal policy; and
(10) adequate treatment services are not uni-
formly available for children with elevated blood lead
levels.
(b) PURPOSE.—The purpose of this Act is to create
a lead screening safety net that will, through the medicaid,
women, infants, and children (WIC), head start and early
head start programs that include infants and toddlers, and
the maternal and child health block grant programs, en-
sure that children covered by those programs receive blood
lead screenings and appropriate followup care.
SEC. 3. INCREASED LEAD POISONING SCREENINGS AND
TREATMENTS UNDER THE MEDICAID PRO-
GRAM.
(a) 
REPORTING
REQUIREMENT.—Section
1902(a)(43)(D) of the Social Security Act (42 U.S.C.
1396a(a)(43)(D)) is amended—
(1) in clause (iii), by striking ‘‘and’’ at the end;
(2) in clause (iv), by striking the semicolon and
inserting ‘‘, and’’; and
(3) by adding at the end the following new
clause:
‘‘(v) the number of children who are
under the age of 3 and enrolled in the
State plan under this title and the number
of those children who have received a blood
lead screening test;’’.
(b) MANDATORY SCREENING REQUIREMENTS.—Sec-
tion 1902(a) of the Social Security Act (42 U.S.C.
1396a(a)) is amended—
(1) in paragraph (64), by striking ‘‘and’’ at the
end;
(2) in paragraph (65), by striking the period
and inserting ‘‘; and’’; and
(3) by inserting after paragraph (65) the fol-
lowing new paragraph:
‘‘(66) provide that each contract entered into
between the State and an entity (including a health
insuring organization and a medicaid managed care
organization) that is responsible for the provision
(directly or through arrangements with providers of
services) of medical assistance under the State plan
shall provide for—
‘‘(A) compliance with mandatory blood
lead screening requirements that are consistent
with prevailing guidelines of the Centers for
Disease Control and Prevention for such screen-
ing; and
‘‘(B) coverage of qualified lead treatment
services described in section 1905(x) including
diagnosis, treatment, and follow-up furnished
for children with elevated blood lead levels in
accordance with prevailing guidelines of the
Centers for Disease Control and Prevention.’’.
(c) REIMBURSEMENT
FOR TREATMENT
OF CHIL-
DREN WITH ELEVATED BLOOD LEAD LEVELS.—Section
1905 of the Social Security Act (42 U.S.C. 1396d) is
amended—
(1) in subsection (a)—
(A) in paragraph (26), by striking ‘‘and’’
at the end;
(B) by redesignating paragraph (27) as
paragraph (28); and
(C) by inserting after paragraph (26) the
following new paragraph:
‘‘(27) qualified lead treatment services (as de-
fined in subsection (x)); and’’; and
(2) by adding at the end the following new sub-
section:
‘‘(x)(1) In this subsection:
‘‘(A) The term ‘qualified lead treatment serv-
ices’ means the following:
‘‘(i) Lead-related medical management, as
defined in subparagraph (B).
‘‘(ii) Lead-related case management, as de-
fined in subparagraph (C), for a child described
in paragraph (2).
‘‘(iii) Lead-related anticipatory guidance,
as defined in subparagraph (D), provided as
part of—
‘‘(I) prenatal services;
‘‘(II) early and periodic screening, di-
agnostic, and treatment services (EPSDT)
described in subsection (r) and available
under subsection (a)(4)(B) (including as
described 
and 
available 
under 
imple-
menting regulations and guidelines) to in-
dividuals enrolled in the State plan under
this title who have not attained age 21;
and
‘‘(III) routine pediatric preventive
services.
‘‘(B) The term ‘lead-related medical manage-
ment’ means the provision and coordination of the
diagnostic, treatment, and follow-up services pro-
vided for a child diagnosed with an elevated blood
lead level (EBLL) that includes—
‘‘(i) a clinical assessment, including a
physical examination and medically indicated
tests (in addition to diagnostic blood lead level
tests) and other diagnostic procedures to deter-
mine the child’s developmental, neurological,
nutritional, and hearing status, and the extent,
duration, and possible source of the child’s ex-
posure to lead;
‘‘(ii) repeat blood lead level tests furnished
when medically indicated for purposes of moni-
toring the blood lead concentrations in the
child;
‘‘(iii) pharmaceutical services, including
chelation agents and other drugs, vitamins, and
minerals prescribed for treatment of an EBLL;
‘‘(iv) medically indicated inpatient services
including pediatric intensive care and emer-
gency services;
‘‘(v) medical nutrition therapy when medi-
cally indicated by a nutritional assessment, that
shall be furnished by a dietitian or other nutri-
tion specialist who is authorized to provide such
services under State law;
‘‘(vi) referral—
‘‘(I) when indicated by a nutritional
assessment, to the State agency or con-
tractor administering the program of as-
sistance under the special supplemental
nutrition program for women, infants and
children (WIC) under section 17 of the
Child Nutrition Act of 1966 (42 U.S.C.
1786) and coordination of clinical manage-
ment with that program; and
‘‘(II) when indicated by a clinical or
developmental assessment, to the State
agency responsible for early intervention
and special education programs under the
Individuals with Disabilities Education Act
(20 U.S.C. 1400 et seq.); and
‘‘(vii) environmental investigation, as de-
fined in subparagraph (E).
‘‘(C) The term ‘lead-related case management’
means the coordination, provision, and oversight of
the nonmedical services for a child with an EBLL
necessary to achieve reductions in the child’s blood
lead levels, improve the child’s nutrition, and secure
needed resources and services to protect the child by
a case manager trained to develop and oversee a
multi-disciplinary plan for a child with an EBLL or
by a childhood lead poisoning prevention program,
as defined by the Secretary. Such services include—
‘‘(i) assessing the child’s environmental,
nutritional, housing, family, and insurance sta-
tus and identifying the family’s immediate
needs to reduce lead exposure through an initial
home visit;
‘‘(ii) developing a multidisciplinary case
management plan of action that addresses the
provision and coordination of each of the fol-
lowing items as appropriate—
‘‘(I) determination of whether or not
such services are covered under the State
plan under this title;
‘‘(II) lead-related medical manage-
ment of an EBLL (including environ-
mental investigation);
‘‘(III) nutrition services;
‘‘(IV) family lead education;
‘‘(V) housing;
‘‘(VI) early intervention services;
‘‘(VII) social services; and
‘‘(VIII) other services or programs
that are indicated by the child’s clinical
status and environmental, social, edu-
cational, housing, and other needs;
‘‘(iii) assisting the child (and the child’s
family) in gaining access to covered and non-
covered services in the case management plan
developed under clause (ii);
‘‘(iv) providing technical assistance to the
provider that is furnishing lead-related medical
management for the child; and
‘‘(v) implementation and coordination of
the case management plan developed under
clause (ii) through home visits, family lead edu-
cation, and referrals.
‘‘(D) The term ‘lead-related anticipatory guid-
ance’ means education and information for families
of children and pregnant women enrolled in the
State plan under this title about prevention of child-
hood lead poisoning that addresses the following top-
ics:
‘‘(i) The importance of lead screening tests
and where and how to obtain such tests.
‘‘(ii) Identifying lead hazards in the home.
‘‘(iii) Specialized cleaning, home mainte-
nance, nutritional, and other measures to mini-
mize the risk of childhood lead poisoning.
‘‘(iv) The rights of families under the Resi-
dential Lead-Based Paint Hazard Reduction
Act of 1992 (42 U.S.C. 4851 et seq.).
‘‘(E) The term ‘environmental investigation’
means the process of determining the source of a
child’s exposure to lead by an individual that is cer-
tified or registered to perform such investigations
under State or local law, including the collection and
analysis of information and environmental samples
from a child’s living environment. For purposes of
this subparagraph, a child’s living environment in-
cludes the child’s residence or residences, residences
of frequently visited caretakers, relatives, and play-
mates, and the child’s day care site. Such investiga-
tions shall be conducted in accordance with the
standards of the Department of Housing and Urban
Development for the evaluation and control of lead-
based paint hazards in housing and in compliance
with State and local health agency standards for en-
vironmental investigation and reporting.
‘‘(2) For purposes of paragraph (1)(A)(ii), a child de-
scribed in this paragraph is a child who—
‘‘(A) has attained 6 months but has not at-
tained 6 years of age; and
‘‘(B) has been identified as having a blood lead
level that equals or exceeds 20 micrograms per deci-
liter (or after 2 consecutive tests, equals or exceeds
15 micrograms per deciliter, or the applicable num-
ber of micrograms designated for such tests under
prevailing guidelines of the Centers for Disease Con-
trol and Prevention).’’.
(d) ENHANCED MATCH FOR DATA COMMUNICATIONS
SYSTEM.—Section 1903(a)(3) of the Social Security Act
(42 U.S.C. 1396b(a)(3)) is amended—
(1) in subparagraph (D), by striking ‘‘plus’’ at
the end and inserting ‘‘and’’; and
(2) by inserting after subparagraph (D), the
following new subparagraph:
‘‘(E)(i) 90 percent of so much of the sums
expended during such quarter as are attrib-
utable to the design, development, or installa-
tion of an information retrieval system that
may be easily accessed and used by other feder-
ally-funded means-tested public benefit pro-
grams to determine whether a child is enrolled
in the State plan under this title and whether
an enrolled child has received mandatory early
and periodic screening, diagnostic, and treat-
ment services, as described in section 1905(r);
and
‘‘(ii) 75 percent of so much of the sums ex-
pended during such quarter as are attributable
to the operation of a system (whether such sys-
tem is operated directly by the State or by an-
other person under a contract with the State)
of the type described in clause (i); plus’’.
(e) REPORT.—The Secretary of Health and Human
Services, acting through the Administrator of the Health
Care Financing Administration, annually shall report to
Congress on the number of children enrolled in the med-
icaid program under title XIX of the Social Security Act
(42 U.S.C. 1396 et seq.) who have received a blood lead
screening test during the prior fiscal year, noting the per-
centage that such children represent as compared to all
children enrolled in that program.
(f) EMERGENCY MEASURES.—
(1) IN GENERAL.—Subject to paragraph (2),
the Secretary of Health and Human Services or the
State agency administering the State plan under
title XIX of the Social Security Act (42 U.S.C. 1396
et seq.) shall use funds provided under title XIX of
that Act to reimburse a State or entity for expendi-
tures for medically necessary activities in the home
of a lead-poisoned child with an EBLL of at least
20, or a pregnant woman with an EBLL of at least
20, to prevent additional exposure to lead, including
specialized cleaning of lead-contaminated dust, emer-
gency relocation, safe repair of peeling paint, dust
control, and other activities that reduce lead expo-
sure. Such reimbursement, when provided by the
State agency administering the State plan under
title XIX of the Social Security Act, shall be consid-
ered medical assistance for purposes of section
1903(a) of such Act.
(2) LIMITATION.—Not more than $1,000 in ex-
penditures for the emergency measures described in
paragraph (1) may be incurred on behalf of a child
or pregnant woman to which that paragraph applies.
(g) RULE OF CONSTRUCTION.—Nothing in this Act
or any amendment made by this Act shall be construed
as requiring a child enrolled in the State medicaid pro-
gram under title XIX of the Social Security Act to under-
go a lead blood screening test if the child’s parent or
guardian objects to the test on the ground that the test
is inconsistent with the parent’s or guardian’s religious be-
liefs.
SEC. 4. BONUS PROGRAM FOR IMPROVEMENT OF CHILD-
HOOD LEAD SCREENING RATES.
(a) IN GENERAL.—The Secretary of Health and
Human Services (in this section referred to as the ‘‘Sec-
retary’’) may establish a program to improve the blood
lead screening rates of States for children under the age
of 3 enrolled in the medicaid program.
(b) PAYMENTS.—If the Secretary establishes a pro-
gram under subsection (a), the Secretary, using State-spe-
cific blood lead screening data, shall, subject to the avail-
ability of appropriations, annually pay a State an amount
determined as follows:
(1) $25 per each 2-year-old child enrolled in the
medicaid program in the State who has received the
minimum required (for that age) screening blood
lead level tests (capillary or venous samples) to de-
termine the presence of elevated blood lead levels, as
established by the Centers for Disease Control and
Prevention, if the State rate for such screenings ex-
ceeds 65 but does not exceed 75 percent of all 2-
year-old children in the State.
(2) $50 per each such child who has received
such minimum required tests if the State rate for
such screenings exceeds 75 but does not exceed 85
percent of all 2-year-old children in the State.
(3) $75 per each such child who has received
such minimum required tests if the State rate for
such screenings exceeds 85 percent of all 2-year-old
children in the State.
(c) USE OF BONUS FUNDS.—Funds awarded to a
State under subsection (b) shall only be used—
(1) by the State department of health in the
case of a child with an elevated blood lead level who
is enrolled in medicaid or another Federal means-
tested program designed to reduce the source of the
child’s exposure to lead; or
(2) in accordance with guidelines for the use of
such funds developed by the Secretary in collabora-
tion with the Secretary of Housing and Urban De-
velopment.
(d) AUTHORIZATION OF APPROPRIATIONS.—There is
authorized to be appropriated to carry out this section,
$30,000,000 for each of fiscal years 2002 through 2006.
SEC. 5. AUTHORIZATION TO USE SCHIP FUNDS FOR BLOOD
LEAD SCREENING.
(a) OPTIONAL APPLICATION TO SCHIP.—
(1) IN
GENERAL.—Section 2107(e)(1) of the
Social Security Act (42 U.S.C. 1397gg(e)(1)) is
amended by adding at the end the following new
subparagraph:
‘‘(E) At State option, section 1902(a)(66)
(relating to blood lead screening and coverage
of qualified lead treatment services defined in
section 1905(x)).’’.
(2) 
CONFORMING
AMENDMENT.—Section
2110(a) of the Social Security Act (42 U.S.C.
1397jj(a)) is amended—
(A) by redesignating paragraph (28) as
paragraph (29); and
(B) by inserting after paragraph (27) the
following new paragraph:
‘‘(28) qualified lead treatment services (as de-
fined in section 1905(x)), but only if the State has
elected under section 2107(e)(1)(E) to apply section
1902(a)(66) to the State child health plan under
this title.’’.
(b) INCLUSION IN MEDICAID REPORTING REQUIRE-
MENT.—
(1) IN
GENERAL.—Section 1902(a)(43)(D)(v)
of 
the 
Social 
Security 
Act 
(42 
U.S.C.
1396a(a)(43)(D)(v)), as added by section 3(a)(3), is
amended by inserting ‘‘or, if the State has elected
under section 2107(e)(1)(E) to apply paragraph
(66) to the State child health plan under title XXI,
in the State plan under title XXI,’’ after ‘‘this title’’.
(2) REPORT
TO
CONGRESS.—Section 3(e) of
this Act is amended—
(A) by inserting ‘‘or in the State children’s
health insurance program under title XXI of
that Act (42 U.S.C 1397aa et seq.)’’ after ‘‘(42
U.S.C. 1396 et seq.)’’; and
(B) by striking ‘‘that program’’ and insert-
ing ‘‘those programs’’.
SEC. 6. LEAD POISONING SCREENING FOR THE HEAD
START AND EARLY HEAD START PROGRAMS.
Section 645A of the Head Start Act (42 U.S.C
9840a) is amended—
(1) in the first sentence of subsection (d), by in-
serting before the period the following: ‘‘and shall
comply with subsection (h)’’; and
(2) by adding at the end the following:
‘‘(h) LEAD POISONING SCREENING.—
‘‘(1) IN GENERAL.—An entity shall—
‘‘(A) determine whether a child eligible to
participate in the program described in sub-
section (a)(1) has received a blood lead screen-
ing test using a test that is appropriate for age
and risk factors upon the enrollment of the
child in the program; and
‘‘(B) in the case of a child who has not re-
ceived a blood lead screening test, ensure that
each enrolled child receives such a test either by
referral or by performing the test (under con-
tract or otherwise).
‘‘(2) SCREENINGS BY ENTITIES.—
‘‘(A) IN GENERAL.—An entity may (under
contract or otherwise) perform a blood lead
screening test that is appropriate for age and
risk factors on a child who seeks to participate
in the program.
‘‘(B) REIMBURSEMENT.—
‘‘(i) CHILDREN ENROLLED IN OR ELI-
GIBLE FOR MEDICAID.—On the request of
an entity that performs or arranges for the
provision of a blood lead screening test
under subparagraph (A) of a child that is
eligible for or receiving medical assistance
under a State plan under title XIX of the
Social Security Act (42 U.S.C. 1396 et
seq.), the Secretary of Health and Human
Services, notwithstanding any other provi-
sion of, or limitation under, title XIX of
the Social Security Act, shall reimburse
the entity, from funds that are made avail-
able under that title, for the Federal med-
ical assistance percentage (as defined in
section 1905(b) of the Social Security Act
(42 U.S.C. 1396d(b)) of the cost of the
test and data reporting. Such costs shall
include, if determined to be desirable by
the State agency, the costs of providing
screening through clinical laboratories cer-
tified under section 353 of the Public
Health Service Act (42 U.S.C. 263a), or
purchasing, for use at sites providing serv-
ices under this section, blood lead testing
instruments and associated supplies ap-
proved for sale by the Food and Drug Ad-
ministration and used in compliance with
such section 353.
‘‘(ii) CHILDREN ENROLLED IN OR EL-
IGIBLE FOR SCHIP.—In the case of a blood
lead screening test performed under sub-
paragraph (A) (by the entity or under con-
tract with the entity) on a child who is eli-
gible for or receiving medical assistance
under a State plan under title XXI of the
Social Security Act, the Secretary of
Health and Human Services, notwith-
standing any other provision of, or limita-
tion under, such title XXI, shall reimburse
the entity, from funds that are made avail-
able under that title, for the enhanced
FMAP (as defined in section 2105(b) of
the 
Social 
Security 
Act 
(42 
U.S.C.
1397ee(b)) of the cost of the test and data
reporting. Such costs shall include the
costs described in the second sentence of
clause (i).
‘‘(3) 
AUTHORIZATION
FOR
EARLY
HEAD
START.—There is authorized to be appropriated
such sums as may be necessary to carry out this
subsection with respect to blood lead screening tests
performed under this subsection on an infant or
child, and any data reporting with respect to such
infant or child, who is not eligible for coverage under
title XIX or XXI of the Social Security Act, or is
not otherwise covered under a health insurance plan.
‘‘(4) HEAD START.—The provisions of this sub-
section shall apply to head start programs that in-
clude coverage, directly or indirectly, for infants and
toddlers under the age of 3 years.’’.
SEC. 7. LEAD POISONING SCREENING FOR SPECIAL SUP-
PLEMENTAL 
NUTRITION 
PROGRAM 
FOR
WOMEN, INFANTS, AND CHILDREN (WIC).
Section 17(d) of the Child Nutrition Act of 1966 (42
U.S.C. 1786(d)) is amended by adding at the end the fol-
lowing:
‘‘(4) LEAD POISONING SCREENING.—
‘‘(A) 
IN
GENERAL.—A 
State 
agency
shall—
‘‘(i) determine whether an infant or
child eligible to participate in the program
under this section has received a blood lead
screening test using a test that is appro-
priate for age and risk factors upon the
enrollment of the infant or child in the
program; and
‘‘(ii) in the case of an infant or child
who has not received a blood lead screen-
ing test—
‘‘(I) refer the infant or child for
receipt of the test; and
‘‘(II) determine whether the in-
fant or child receives the test during
a routine visit with a health care pro-
vider.
‘‘(B) SCREENINGS BY STATE AGENCIES.—
‘‘(i) IN
GENERAL.—A State agency
may (under contract or otherwise) perform
a blood lead screening test that is appro-
priate for age and risk factors on an infant
or child who seeks to participate in the
program.
‘‘(ii) REIMBURSEMENT.—
‘‘(I) CHILDREN ENROLLED IN OR
ELIGIBLE FOR MEDICAID.—On the re-
quest of a State agency that performs
or arranges for the provision of a
blood lead screening test under clause
(i) of an infant or child that is eligible
for or receiving medical assistance
under a State plan under title XIX of
the Social Security Act (42 U.S.C.
1396 et seq.), the Secretary of Health
and Human Services, notwithstanding
any other provision of, or limitation
under, title XIX of the Social Security
Act, shall reimburse the State agency,
from funds that are made available
under that title, for the Federal med-
ical assistance percentage (as defined
in section 1905(b) of the Social Secu-
rity Act (42 U.S.C. 1396d(b)) of the
cost of the test and data reporting.
Such costs shall include, if determined
to be desirable by the State agency,
the 
costs 
of 
providing 
screening
through clinical laboratories certified
under section 353 of the Public
Health Service Act (42 U.S.C. 263a),
or purchasing, for use at sites pro-
viding services under this section,
blood lead testing instruments and as-
sociated supplies approved for sale by
the Food and Drug Administration
and used in compliance with such sec-
tion 353.
‘‘(II) CHILDREN
ENROLLED
IN
OR ELIGIBLE FOR SCHIP.—In the case
of a blood lead screening test per-
formed under clause (i) (by the State
agency or under contract with the
State agency) on an infant or child
who is eligible for or receiving medical
assistance under a State plan under
title XXI of the Social Security Act,
the Secretary of Health and Human
Services, notwithstanding any other
provision of, or limitation under, such
title XXI, shall reimburse the State
agency, from funds that are made
available under that title, for the en-
hanced FMAP (as defined in section
2105(b) of the Social Security Act (42
U.S.C. 1397ee(b)) of the cost of the
test and data reporting. Such costs
shall include the costs described in the
second sentence of subclause (I).
‘‘(C) AUTHORIZATION FOR WIC.—There is
authorized to be appropriated such sums as
may be necessary to carry out this paragraph
with respect to blood lead screening tests per-
formed under this paragraph on an infant or
child, and any data reporting with respect to
such infant or child, who is not eligible for cov-
erage under title XIX or XXI of the Social Se-
curity Act, or is not otherwise covered under a
health insurance plan.’’.
SEC. 8. EFFECTIVE DATE.
(a) IN GENERAL.—Except as provided in subsection
(b), the amendments made by this Act take effect on the
date that is 18 months after the date of enactment of this
Act.
(b) WIC AND EARLY HEAD START WAIVERS.—
(1) IN GENERAL.—A State agency or contractor
administering the program of assistance under the
special supplemental nutrition program for women,
infants and children (WIC) under section 17 of the
Child Nutrition Act of 1966 (42 U.S.C. 1786), or an
entity carrying out activities under section 645A of
the Head Start Act (42 U.S.C. 9840a) may be
awarded a waiver from the amendments made by
sections 6 and 7 (as applicable) if the State where
the agency, contractor, or entity is located estab-
lishes to the satisfaction of the Secretary of Health
and Human Services, in accordance with require-
ments and procedures recommended in accordance
with paragraph (2) to the Secretary by the Director
of the Centers for Disease Control and Prevention,
in consultation with the Centers for Disease Control
and Prevention Advisory Committee on Childhood
Lead Poisoning Prevention, a plan for increasing the
number of blood lead screening tests of children en-
rolled in the WIC and the Early Head Start pro-
grams in the State.
(2) DEVELOPMENT
OF
WAIVER
PROCEDURES
AND
REQUIREMENTS.—Not later than 12 months
after the date of enactment of this Act, the Director
of the Centers for Disease Control and Prevention,
in consultation with the Centers for Disease Control
and Prevention Advisory Committee on Childhood
Lead Poisoning Prevention, shall develop and rec-
ommend to the Secretary of Health and Human
Services criteria and procedures (including a time-
table for the submission of the State plan described
in paragraph (1)) for the award of waivers under
that paragraph.
Æ